Analyze Diet
Gene2002; 283(1-2); 263-269; doi: 10.1016/s0378-1119(01)00880-0

DNA-PKcs mutations in dogs and horses: allele frequency and association with neoplasia.

Abstract: Previously, spontaneous genetic immunodeficiencies in mice, Arabian foals, and recently in Jack Russell terriers have been ascribed to defects in DNA-PKcs (catalytic subunit of the DNA dependent protein kinase) expression. In severe combined immunodeficiency (SCID) foals, a 5 bp deletion at codon 9480 results in a frameshift and a 967 amino acid deletion from the C terminus (including the entire PI3 kinase domain) and an unstable mutant protein. In SCID mice, a single base pair mutation results in a premature stop codon and deletion of 83 amino acids; as in SCID foals, the mutant protein is unstable. Here, we define the mutation within the canine DNA-PKcs gene that results in SCID. In this case, a point mutation results in a stop codon at nucleotide 10,828 and premature termination at a position 517 amino acids before the normal C terminus resulting in a functionally null allele. Thus, this is the third documentation of a spontaneous germline mutation in the C terminus of DNA-PKcs. Emerging data implicate DNA repair factors as potential tumor suppressors. Here, we have ascertained the carrier frequency of the defective DNA-PKcs genes in Arabian horses and in Jack Russell terriers. Our data indicate (in good agreement with a previous report) that the carrier frequency of the equine SCID allele is approximately 8%; in contrast, the carrier frequency of the canine SCID allele is less than 1.1%. We also assessed the frequency of the equine SCID allele in a series of 295 tumors from Arabian horses. We find a statistically significant correlation between the development of a virally induced tumor (sarcoid) and heterozygosity for the equine SCID allele. These data provide further support for an emerging consensus: that DNA-PK may normally act as a tumor suppressor through its caretaker role in maintaining chromosomal stability.
Publication Date: 2002-02-28 PubMed ID: 11867233DOI: 10.1016/s0378-1119(01)00880-0Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research focuses on mutational defects in DNA-PKcs gene, found in Arabian horses and Jack Russell Terriers, which result in severe combined immunodeficiency (SCID), and proposes a potential correlation between these mutations and the development of certain tumors in these animals.

Mutations in the DNA-PKcs Gene

  • DNA-PKcs, also known as the catalytic subunit of the DNA dependent protein kinase, is of particular interest due to its essential role in non-homologous end joining (NHEJ), a process vital for repairing double-strand breaks in DNA.
  • The researchers have identified the mutation within the canine DNA-PKcs gene that results in SCID, in this case, it is a point mutation leading to the occurrence of a stop codon at nucleotide 10,828. This results in the premature termination of protein synthesis at a position 517 amino acids before the normal C terminus, creating a functionally null allele.
  • The mutation in SCID horses, distinctively, is a 5 base pair deletion at codon 9480 that leads to a frameshift and a deletion of 967 amino acids from the C terminus. This includes the entire PI3 kinase domain and results in an unstable mutant protein.

Frequency of Mutations and Association with Neoplasia

  • The researchers have also evaluated the carrier frequency of defective DNA-PKcs genes in Arabian horses and Jack Russell terriers. The findings indicate approximately 8% carrier frequency of the SCID allele in Arabian horses, whereas in Jack Russell terriers, the carrier frequency of the SCID allele is found to be less than 1.1%.
  • The team further studied the frequency of the equine SCID allele in a sample of 295 tumors from Arabian horses, unearthing a significant statistical correlation between the development of a specific type of virally induced tumor (sarcoid) and the presence of the equine SCID allele.
  • These findings therefore propose DNA-PKcs as a potential tumor suppressor, asserting that its primary role might maintain chromosomal stability, hence preventing the development of tumors. This discovery can contribute to the broader understanding of the role of DNA repair factors in cancer biology.

Cite This Article

APA
Ding Q, Bramble L, Yuzbasiyan-Gurkan V, Bell T, Meek K. (2002). DNA-PKcs mutations in dogs and horses: allele frequency and association with neoplasia. Gene, 283(1-2), 263-269. https://doi.org/10.1016/s0378-1119(01)00880-0

Publication

ISSN: 0378-1119
NlmUniqueID: 7706761
Country: Netherlands
Language: English
Volume: 283
Issue: 1-2
Pages: 263-269

Researcher Affiliations

Ding, Qi
  • College of Veterinary Medicine, Michigan State University, East Lansing, MI 48824, USA.
Bramble, Lori
    Yuzbasiyan-Gurkan, Vilma
      Bell, Thomas
        Meek, Katheryn

          MeSH Terms

          • Amino Acid Sequence
          • Animals
          • Base Sequence
          • Catalytic Domain / genetics
          • Codon, Nonsense
          • DNA Mutational Analysis
          • DNA, Complementary / chemistry
          • DNA, Complementary / genetics
          • DNA, Neoplasm / genetics
          • DNA-Activated Protein Kinase
          • DNA-Binding Proteins
          • Dogs
          • Gene Frequency
          • Genotype
          • Heterozygote
          • Horses
          • Molecular Sequence Data
          • Mutation
          • Neoplasms / enzymology
          • Neoplasms / genetics
          • Neoplasms / pathology
          • Point Mutation
          • Protein Serine-Threonine Kinases / genetics

          Grant Funding

          • R24 RR016537 / NCRR NIH HHS
          • AI32600 / NIAID NIH HHS
          • AI42938 / NIAID NIH HHS

          Citations

          This article has been cited 15 times.
          1. Matsumoto Y, Asa ADDC, Modak C, Shimada M. DNA-Dependent Protein Kinase Catalytic Subunit: The Sensor for DNA Double-Strand Breaks Structurally and Functionally Related to Ataxia Telangiectasia Mutated. Genes (Basel) 2021 Jul 27;12(8).
            doi: 10.3390/genes12081143pubmed: 34440313google scholar: lookup
          2. Sui J, Zhang S, Chen BPC. DNA-dependent protein kinase in telomere maintenance and protection. Cell Mol Biol Lett 2020;25:2.
            doi: 10.1186/s11658-020-0199-0pubmed: 31988640google scholar: lookup
          3. Koike M, Yutoku Y, Koike A. Cloning, localization and focus formation at DNA damage sites of canine XLF. J Vet Med Sci 2017 Jan 20;79(1):22-28.
            doi: 10.1292/jvms.16-0440pubmed: 27746407google scholar: lookup
          4. Neal JA, Xu Y, Abe M, Hendrickson E, Meek K. Restoration of ATM Expression in DNA-PKcs-Deficient Cells Inhibits Signal End Joining. J Immunol 2016 Apr 1;196(7):3032-42.
            doi: 10.4049/jimmunol.1501654pubmed: 26921311google scholar: lookup
          5. Koike M, Yutoku Y, Koike A. Dynamic changes in subcellular localization of cattle XLF during cell cycle, and focus formation of cattle XLF at DNA damage sites immediately after irradiation. J Vet Med Sci 2015 Sep;77(9):1109-14.
            doi: 10.1292/jvms.14-0516pubmed: 25947322google scholar: lookup
          6. Lee BS, Gapud EJ, Zhang S, Dorsett Y, Bredemeyer A, George R, Callen E, Daniel JA, Osipovich O, Oltz EM, Bassing CH, Nussenzweig A, Lees-Miller S, Hammel M, Chen BP, Sleckman BP. Functional intersection of ATM and DNA-dependent protein kinase catalytic subunit in coding end joining during V(D)J recombination. Mol Cell Biol 2013 Sep;33(18):3568-79.
            doi: 10.1128/MCB.00308-13pubmed: 23836881google scholar: lookup
          7. Runkle EA, Zhang H, Cai Z, Zhu Z, Karger BL, Wu SL, O'Rourke DM, Zhou Z, Wang Q, Greene MI. Reversion of the ErbB malignant phenotype and the DNA damage response. Exp Mol Pathol 2012 Dec;93(3):324-33.
            doi: 10.1016/j.yexmp.2012.09.007pubmed: 23022358google scholar: lookup
          8. Brosnahan MM, Brooks SA, Antczak DF. Equine clinical genomics: A clinician's primer. Equine Vet J 2010 Oct;42(7):658-70.
          9. Meek K, Jutkowitz A, Allen L, Glover J, Convery E, Massa A, Mullaney T, Stanley B, Rosenstein D, Bailey SM, Johnson C, Georges G. SCID dogs: similar transplant potential but distinct intra-uterine growth defects and premature replicative senescence compared with SCID mice. J Immunol 2009 Aug 15;183(4):2529-36.
            doi: 10.4049/jimmunol.0801406pubmed: 19635917google scholar: lookup
          10. Bauer TR Jr, Adler RL, Hickstein DD. Potential large animal models for gene therapy of human genetic diseases of immune and blood cell systems. ILAR J 2009;50(2):168-86.
            doi: 10.1093/ilar.50.2.168pubmed: 19293460google scholar: lookup
          11. Ruis BL, Fattah KR, Hendrickson EA. The catalytic subunit of DNA-dependent protein kinase regulates proliferation, telomere length, and genomic stability in human somatic cells. Mol Cell Biol 2008 Oct;28(20):6182-95.
            doi: 10.1128/MCB.00355-08pubmed: 18710952google scholar: lookup
          12. Flint AP, Woolliams JA. Precision animal breeding. Philos Trans R Soc Lond B Biol Sci 2008 Feb 12;363(1491):573-90.
            doi: 10.1098/rstb.2007.2171pubmed: 17656344google scholar: lookup
          13. Beskow C, Kanter L, Holgersson A, Nilsson B, Frankendal B, Avall-Lundqvist E, Lewensohn R. Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB-IIA of cervical cancer. Br J Cancer 2006 Jun 5;94(11):1683-9.
            doi: 10.1038/sj.bjc.6603153pubmed: 16685270google scholar: lookup
          14. Woods T, Wang W, Convery E, Errami A, Zdzienicka MZ, Meek K. A single amino acid substitution in DNA-PKcs explains the novel phenotype of the CHO mutant, XR-C2. Nucleic Acids Res 2002 Dec 1;30(23):5120-8.
            doi: 10.1093/nar/gkf625pubmed: 12466535google scholar: lookup
          15. Douglas P, Sapkota GP, Morrice N, Yu Y, Goodarzi AA, Merkle D, Meek K, Alessi DR, Lees-Miller SP. Identification of in vitro and in vivo phosphorylation sites in the catalytic subunit of the DNA-dependent protein kinase. Biochem J 2002 Nov 15;368(Pt 1):243-51.
            doi: 10.1042/BJ20020973pubmed: 12186630google scholar: lookup